Estimation of country-level incidence of early-onset invasive Group B Streptococcus disease in infants using Bayesian methods.

Neonatal invasive disease caused by Group B Streptococcus (GBS) is responsible for much acute mortality and long-term morbidity. To guide development of better prevention strategies, including maternal vaccines that protect neonates against GBS, it is necessary to estimate the burden of this conditi...

Full description

Saved in:
Bibliographic Details
Main Authors: Bronner P Gonçalves, Simon R Procter, Sam Clifford, Artemis Koukounari, Proma Paul, Alexandra Lewin, Mark Jit, Joy Lawn
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-06-01
Series:PLoS Computational Biology
Online Access:https://journals.plos.org/ploscompbiol/article/file?id=10.1371/journal.pcbi.1009001&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849469966133231616
author Bronner P Gonçalves
Simon R Procter
Sam Clifford
Artemis Koukounari
Proma Paul
Alexandra Lewin
Mark Jit
Joy Lawn
author_facet Bronner P Gonçalves
Simon R Procter
Sam Clifford
Artemis Koukounari
Proma Paul
Alexandra Lewin
Mark Jit
Joy Lawn
author_sort Bronner P Gonçalves
collection DOAJ
description Neonatal invasive disease caused by Group B Streptococcus (GBS) is responsible for much acute mortality and long-term morbidity. To guide development of better prevention strategies, including maternal vaccines that protect neonates against GBS, it is necessary to estimate the burden of this condition globally and in different regions. Here, we present a Bayesian model that estimates country-specific invasive GBS (iGBS) disease incidence in children aged 0 to 6 days. The model combines different types of epidemiological data, each of which has its own limitations: GBS colonization prevalence in pregnant women, risk of iGBS disease in children born to GBS-colonized mothers and direct estimates of iGBS disease incidence where available. In our analysis, we present country-specific maternal GBS colonization prevalence after adjustment for GBS detection assay used in epidemiological studies. We then integrate these results with other epidemiological data and estimate country-level incidence of iGBS disease including in countries with no studies that directly estimate incidence. We are able to simultaneously estimate two key epidemiological quantities: the country-specific incidence of early-onset iGBS disease, and the risk of iGBS disease in babies born to GBS-colonized women. Overall, we believe our method will contribute to a more comprehensive quantification of the global burden of this disease, inform cost-effectiveness assessments of potential maternal GBS vaccines and identify key areas where data are necessary.
format Article
id doaj-art-dbefa243120e4297b86297c192e1b694
institution Kabale University
issn 1553-734X
1553-7358
language English
publishDate 2021-06-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Computational Biology
spelling doaj-art-dbefa243120e4297b86297c192e1b6942025-08-20T03:25:16ZengPublic Library of Science (PLoS)PLoS Computational Biology1553-734X1553-73582021-06-01176e100900110.1371/journal.pcbi.1009001Estimation of country-level incidence of early-onset invasive Group B Streptococcus disease in infants using Bayesian methods.Bronner P GonçalvesSimon R ProcterSam CliffordArtemis KoukounariProma PaulAlexandra LewinMark JitJoy LawnNeonatal invasive disease caused by Group B Streptococcus (GBS) is responsible for much acute mortality and long-term morbidity. To guide development of better prevention strategies, including maternal vaccines that protect neonates against GBS, it is necessary to estimate the burden of this condition globally and in different regions. Here, we present a Bayesian model that estimates country-specific invasive GBS (iGBS) disease incidence in children aged 0 to 6 days. The model combines different types of epidemiological data, each of which has its own limitations: GBS colonization prevalence in pregnant women, risk of iGBS disease in children born to GBS-colonized mothers and direct estimates of iGBS disease incidence where available. In our analysis, we present country-specific maternal GBS colonization prevalence after adjustment for GBS detection assay used in epidemiological studies. We then integrate these results with other epidemiological data and estimate country-level incidence of iGBS disease including in countries with no studies that directly estimate incidence. We are able to simultaneously estimate two key epidemiological quantities: the country-specific incidence of early-onset iGBS disease, and the risk of iGBS disease in babies born to GBS-colonized women. Overall, we believe our method will contribute to a more comprehensive quantification of the global burden of this disease, inform cost-effectiveness assessments of potential maternal GBS vaccines and identify key areas where data are necessary.https://journals.plos.org/ploscompbiol/article/file?id=10.1371/journal.pcbi.1009001&type=printable
spellingShingle Bronner P Gonçalves
Simon R Procter
Sam Clifford
Artemis Koukounari
Proma Paul
Alexandra Lewin
Mark Jit
Joy Lawn
Estimation of country-level incidence of early-onset invasive Group B Streptococcus disease in infants using Bayesian methods.
PLoS Computational Biology
title Estimation of country-level incidence of early-onset invasive Group B Streptococcus disease in infants using Bayesian methods.
title_full Estimation of country-level incidence of early-onset invasive Group B Streptococcus disease in infants using Bayesian methods.
title_fullStr Estimation of country-level incidence of early-onset invasive Group B Streptococcus disease in infants using Bayesian methods.
title_full_unstemmed Estimation of country-level incidence of early-onset invasive Group B Streptococcus disease in infants using Bayesian methods.
title_short Estimation of country-level incidence of early-onset invasive Group B Streptococcus disease in infants using Bayesian methods.
title_sort estimation of country level incidence of early onset invasive group b streptococcus disease in infants using bayesian methods
url https://journals.plos.org/ploscompbiol/article/file?id=10.1371/journal.pcbi.1009001&type=printable
work_keys_str_mv AT bronnerpgoncalves estimationofcountrylevelincidenceofearlyonsetinvasivegroupbstreptococcusdiseaseininfantsusingbayesianmethods
AT simonrprocter estimationofcountrylevelincidenceofearlyonsetinvasivegroupbstreptococcusdiseaseininfantsusingbayesianmethods
AT samclifford estimationofcountrylevelincidenceofearlyonsetinvasivegroupbstreptococcusdiseaseininfantsusingbayesianmethods
AT artemiskoukounari estimationofcountrylevelincidenceofearlyonsetinvasivegroupbstreptococcusdiseaseininfantsusingbayesianmethods
AT promapaul estimationofcountrylevelincidenceofearlyonsetinvasivegroupbstreptococcusdiseaseininfantsusingbayesianmethods
AT alexandralewin estimationofcountrylevelincidenceofearlyonsetinvasivegroupbstreptococcusdiseaseininfantsusingbayesianmethods
AT markjit estimationofcountrylevelincidenceofearlyonsetinvasivegroupbstreptococcusdiseaseininfantsusingbayesianmethods
AT joylawn estimationofcountrylevelincidenceofearlyonsetinvasivegroupbstreptococcusdiseaseininfantsusingbayesianmethods